VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,987,000 | +69.3% | 142,832 | +113.0% | 0.13% | +641.2% |
| Q1 2016 | $1,764,000 | -73.5% | 67,054 | +2.6% | 0.02% | -72.6% |
| Q4 2015 | $6,647,000 | +0.7% | 65,386 | +76.6% | 0.06% | -23.5% |
| Q3 2015 | $6,604,000 | -77.5% | 37,021 | -72.0% | 0.08% | -78.9% |
| Q2 2015 | $29,379,000 | +2855.6% | 132,247 | +2541.8% | 0.38% | +2846.2% |
| Q1 2015 | $994,000 | -93.7% | 5,006 | -95.5% | 0.01% | -93.8% |
| Q4 2014 | $15,870,000 | +127.1% | 110,894 | +108.2% | 0.21% | +107.9% |
| Q3 2014 | $6,987,000 | +747.9% | 53,256 | +751.6% | 0.10% | +573.3% |
| Q1 2014 | $824,000 | – | 6,254 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |